Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 8Genitourinary 6Breast 6Thoracic 5Gynecologic 5Gastrointestinal 5Tumor-Agnostic 4Plasma cell 4Other hematologic neoplasm 4Sarcoma 2Head & Neck 2Other solid neoplasm 1Myeloid 1

Conditions

Head and Neck Neoplasms 2Neoplasms 1Frailty 1

Interventions

Cisplatin 631Radiotherapy 339pembrolizumab 329Cetuximab 284Docetaxel 226Radiotherapy, Intensity-Modulated 221Fluorouracil 199Carboplatin 198Paclitaxel 161Nivolumab 145Gemcitabine 125Magnetic Resonance Spectroscopy 99Radiation 91Drug Therapy 86Capecitabine 77toripalimab 75Surveys and Questionnaires 73Surgical Procedures, Operative 72Biopsy 62durvalumab 61Chemoradiotherapy 52Blood Specimen Collection 52Cyclophosphamide 50Specimen Handling 47camrelizumab 46Radiosurgery 46Erlotinib Hydrochloride 46Standard of Care 44130-nm albumin-bound paclitaxel 44tislelizumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Geriatric Assessment × Head & Neck × Clear all
NCT06638216 2025-08-28

PRE-KOVERI

Charite University, Berlin, Germany

Phase NA Completed
99 enrolled
Head & Neck

Frailty, Head and Neck Neoplasms

NCT01688323 2017-09-12

Finding Predictors of Side Effects to Chemoradiation Treatment in Elderly Patients With Head and Neck Cancer

UNC Lineberger Comprehensive Cancer Center

Completed
3 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡